Review and Comment Sample Clauses

Review and Comment. The Company shall permit the Holder and a single firm of counsel, as designated by him to review and comment upon the Registration Statement and all amendments and supplements thereto at least three (3) business days prior to the filing thereof with the SEC, and not file any document in a form to which such counsel reasonably objects. The Company shall not submit to the SEC a request for acceleration of the effectiveness of the Registration Statement or file with the SEC the Registration Statement or any amendment or supplement thereto without the prior approval of such counsel, which approval shall not be unreasonably withheld.
Review and Comment. Genentech shall provide Lexicon with a copy of any patent application (including any provisional applications) within (i) Project Patents and (ii) Lexicon Pre-Existing Patents or Restricted Rights Project Patents relating to Protein Candidates prior to filing in any jurisdiction for review and comment by Lexicon. Genentech shall reasonably consider comments and suggestions provided in a timely manner by Lexicon. Lexicon shall maintain any such applications in confidence.
Review and Comment. OPKO shall keep Pfizer advised on the status of the prosecution and maintenance of all Licensed Products and Compounds of the OPKO Prosecuted IP in the ordinary course of patent prosecution and in such manner as OPKO or OPKO’s counsel and/or management is informed. OPKO shall provide quarterly docket reports as well as updated docket reports as requested by Pfizer for all Licensed Product and Compounds of the OPKO Prosecuted IP. For the Major Market Countries, and any other countries or patent offices specifically requested in writing by Pfizer, OPKO shall allow Pfizer a reasonable opportunity and reasonable time to review and comment regarding substantive communications from the relevant patent offices or Governmental Authorities and drafts of any responses or other proposed substantive filings before any such filings are submitted to any relevant patent offices or Governmental Authorities, and OPKO shall consider in good faith any reasonable comments offered by Pfizer in preparing any final filings to be submitted to any relevant patent offices or Governmental Authorities.
Review and Comment. MorphoSys shall have the right to review and comment before each act of Xencor’s filing and/or prosecution of Licensed Candidate-Specific Patents, Licensed Broader Anti-CD19 Patents and Xencor Pre-Sublicensing Product Invention Patents. Xencor shall have the right to review and comment before each act of MorphoSys’s prosecution of Joint Collaboration Product Invention Patents and MorphoSys Product Invention Patents. For each of the foregoing, each Party shall provide the other Party with a copy of each substantive communication received from any patent authority within a reasonable time (ideally, within […***…] of the respective mailing date); and a copy of each proposed submission to a patent authority in the MorphoSys Territory regarding such Patent reasonably in advance of making such filing (normally […***…] in advance but sometimes less under exigent circumstances). Furthermore, with respect to the preparation, filing, prosecution and maintenance of each such Patents each Party agrees to the following: (i) keep the other Party reasonably informed with respect to such activities; (ii) consult with the other Party regarding such matters, including the final abandonment of any such Patent claims; and (iii) reasonably consider the other Party’s comments.
Review and Comment. In connection with an Underwritten Shelf Takedown or Piggyback Registration, at least 5 Business Days before filing a registration statement (other than the initial registration statement, in which case such period shall be at least 15 Business Days), prospectus, prospectus supplement or an amendment to the foregoing with the SEC, the Issuer shall furnish InvestorsCounsel with such documents, and such documents are subject to the reasonable review, comment and approval of such counsel before filing.
Review and Comment. Lexicon shall provide Genentech with a copy of any patent application (including any provisional applications) within Lexicon Knock-Out Technology specifically related to a Protein Candidate prior to filing in any jurisdiction, for review and comment by Genentech. Lexicon shall reasonably consider comments and suggestions provided in a timely manner by Genentech. Genentech shall maintain any such applications in confidence.
Review and Comment. In the event the Department of the Army shall, pursuant to the terms of the Feasibility Agreement, allow Port KC the opportunity to review and comment on any action to be undertaken by the Department of the Army in performing the Study, Port KC shall seek review and comment from Project Partner prior to responding to the same, and shall include such review and comment in any response it may provide to the Department of the Army.
Review and Comment. With respect to Joint Project Patents, the Prosecuting Party shall, or shall instruct the Outside Patent Counsel to: (1) keep both Parties informed as to the Prosecution and Maintenance (including as pertains to which countries in which to initiate or continue prosecution (including validation) and questions of the scope, issuance, or rejection of an interference involving or an opposition to any such Patents), such that each Party has sufficient time to review and comment on any documents intended for submission to any patent office; (2) promptly furnish to each Party a copy of any patent application and copies of documents relevant to such Prosecution and Maintenance, including copies of correspondence with any patent office, foreign associates, and outside counsel; and (3) reasonably consider and incorporate comments of both Parties on documents filed with any patent office.
Review and Comment. Each Party shall provide the Program Chairs ------------------ with a copy of any patent application which first discloses any specific Program Know-How prior to filing the first of such applications in any jurisdiction for review and comment by the Program Chairs or its designees. The Program Chairs and/or its designees shall maintain any such patent application in confidence, pursuant to Article VIII.
Review and Comment. In connection with any Joint Inventions or Scriptgen Compound Inventions, each party shall provide the other party with a copy of any patent application which first discloses any specific invention within the scope of the Project or other relevant Project IP-Rights and information prior to first filing the first of such applications in any jurisdiction, if possible, for review and comment by each party, or its respective designees, Each party and designees thereof shall maintain any such patent application in confidence pursuant to Article VIII.